Abstract:ConspectusCell therapy has become a momentum-gathering treatment strategy for a variety of diseases, including cancer, diabetes, hemophilia, and cardiomyopathy. However, clinical applications of conventional cell therapies have often been compromised by rapid decline in viability and function of the transplanted cells due to host recognition and subsequent foreign body rejection. Along this line, cell engineering technologies such as cell encapsulation within microcapsules and immobilization in porous scaffolds have been implemented to address the immunosuppression concerns. As a recent emerging research topic, drawing inspiration from the ways that natural cells interact with the body has opened new avenues for cell engineering, such as direct modification of whole cells with synthetic materials and "top-down" integration of biological membranes with micro/nanomaterials, which aim to alleviate immune response while harnessing the complex biological functions of cells.In this Account, we summarize our recent contribution to the field of cell engineering methodologies, with which we have demonstrated their promising applications for cancer immunotherapy, targeted drug delivery, and blood glucose regulation. For example, inspired by the inherent ability of platelets to accumulate at wound sites and interact with circulating tumor cells, we exploited a targeted checkpoint antibody delivery strategy for treatment of postsurgical cancer recurrence and metastatic spread by covalent binding of platelets' cell surfaces with a monoclonal antibody against programmed-death ligand 1 (aPDL1). Without interfering with the platelets' surgical-site homing property, the conjugated aPDL1 could be triggered to release in the form of microparticles after in situ activation. As an extension, we then engineered the platelet membrane to cloak nanoparticles for anticancer drug delivery, mimicking the targeting capability of the source cells while possessing prolonged circulation lifetime and insignificant immunogenicity. At the same time, we also found that the subcellular compartment membrane-derived particulates exhibited high specificity toward homotypic cells, by which enhanced intracellular drug delivery was achieved. Moreover, by taking advantage of the reversible interaction between glucose-derivative-modified insulin and the red blood cell membrane, we constructed a glucose-responsive smart insulin delivery system for long-term maintenance of blood glucose levels within a normal range. Recently, by virtue of painless microneedle patches as convenient cell engineering platforms, a minimally invasive intradermal antitumor vaccine was invented by integrating whole-tumor lysis into near-infrared light-illuminated microneedle patches. The microneedle patches also showed promise in combining with conventional cell encapsulation techniques, by which an externally positioned β-cell engineering strategy was proposed for diabetes treatment. The results presented in this Account demonstrate distinct approaches to the development and application of cell engineering strategies for drug delivery.

Pathology-targeted Cell Delivery Via Injectable Micro-Scaffold Capsule Mediated by Endogenous TGase.

TGase-mediated cell membrane modification and targeted cell delivery to inflammatory endothelium

Promoting The Recruitment, Engagement, And Reinvigoration of Effector T Cells via An Injectable Hydrogel with A Supramolecular Binding Capability for Cancer Immunotherapy

Enhanced Cellular Uptake by Non-Endocytic Pathway for Tumor Therapy

Stepwise Targeted Drug Delivery to Liver Cancer Cells for Enhanced Therapeutic Efficacy by Galactose-Grafted, Ultra-Ph-sensitive Micelles.

Surface-engineering of Glycidyl Methacrylated Dextran/gelatin Microcapsules with Thermo-Responsive Poly(n-Isopropylacrylamide) Gates for Controlled Delivery of Stromal Cell-Derived Factor-1Α.

Sweet and sticky: increased cell adhesion through click-mediated functionalization of regenerative liver progenitor cells

Targeted Delivery of Cargoes into A Murine Solid Tumor by A Cell-Penetrating Peptide and Cleavable Poly(Ethylene Glycol) Comodified Liposomal Delivery System Via Systemic Administration

Leveraging Engineering of Cells for Drug Delivery

Surface-anchored tumor microenvironment-responsive protein nanogel-platelet system for cytosolic delivery of therapeutic protein in the post-surgical cancer treatment

Fully Bioactive Nanodrugs: Stem Cell-Derived Exosomes Engineered with Biomacromolecules to Treat CCl4- and Extreme Hepatectomy-Induced Acute Liver Failure

A Nano-In-Micro System for Enhanced Stem Cell Therapy of Ischemic Diseases

Molecular force-induced liberation of transforming growth factor-beta remodels the spleen for ectopic liver regeneration

Potent cancer therapy by liposome microstructure tailoring with active-to-passive targeting and shell-to-core thermosensitive features

Enhancing therapeutic effects and <i>in vivo</i> tracking of adipose tissue-derived mesenchymal stem cells for liver injury using bioorthogonal click chemistry

Novel Dual CAFs and Cancer Cell Targeting Nano-Drug Delivery System for Anti-Fibrosis Mechanism of Liver Cancer

Local and Targeted Delivery of Immune Checkpoint Blockade Therapeutics.

Lipophilic recombinant-protein insertion endows lymphocytes with enhanced targeting-infiltration ability in EGFR positive cancer

Artificial “Nano-Targeted Cells” for Bimodal Imaging-Guided Tumor Cocktail Therapy

In vitro performance of an injectable hydrogel/microsphere based immunocyte delivery system for localised anti-tumour activity.

TPGS and Chondroitin Sulfate Dual-Modified Lipid-Albumin Nanosystem for Targeted Delivery of Chemotherapeutic Agent Against Multidrug-Resistant Cancer